Impact of obesity upon prostate cancer-associated mortality: A meta-analysis of 17 cohort studies
- PMID: 25663903
- PMCID: PMC4315023
- DOI: 10.3892/ol.2014.2841
Impact of obesity upon prostate cancer-associated mortality: A meta-analysis of 17 cohort studies
Abstract
A number of epidemiological studies have suggested that obesity is associated, albeit inconsistently, with the incidence of prostate cancer (PCa). In order to provide a quantitative assessment of this association, the present study examined the correlation between obesity and the incidence and associated mortalities of PCa in an updated meta-analysis of cohort studies. The cohort studies were identified by searching the EMBASE and MEDLINE databases on January 1, 2014. The summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated using random-effects models. In total, 17 studies, which included 3,569,926 individuals overall, were selected according to predefined inclusion criteria. Based upon the results of the random-effects models, obesity was not significantly correlated with the incidence of PCa (RR, 1.00; 95% CI, 0.95-1.06). However, further analysis revealed that obesity was significantly correlated with an increased risk of aggressive PCa (RR, 1.14; 95% CI, 1.04-1.25). Furthermore, an increased risk of PCa-associated mortality was significantly associated with obesity (RR, 1.24; 95% CI, 1.15-2.33), without any heterogeneity between the studies (I2=0.0%; P=0.847). The present study provides preliminary evidence to demonstrate that obesity is a significant risk factor for aggressive PCa and PCa-specific mortality. The low survival rates observed among obese males with PCa may be a likely explanation for this association.
Keywords: incidence; meta-analysis; mortality; obesity; prospective cohort studies; prostate cancer.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4315023/bin/OL-09-03-1307-g00.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4315023/bin/OL-09-03-1307-g01.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4315023/bin/OL-09-03-1307-g02.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4315023/bin/OL-09-03-1307-g03.gif)
Similar articles
-
A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies.Eur Urol. 2014 Dec;66(6):1054-64. doi: 10.1016/j.eururo.2014.08.059. Epub 2014 Sep 18. Eur Urol. 2014. PMID: 25242554 Free PMC article. Review.
-
Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis.Ann Oncol. 2018 May 1;29(5):1154-1179. doi: 10.1093/annonc/mdy073. Ann Oncol. 2018. PMID: 29788165
-
Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies.Ann Oncol. 2012 Jul;23(7):1665-71. doi: 10.1093/annonc/mdr603. Epub 2012 Jan 6. Ann Oncol. 2012. PMID: 22228452 Review.
-
Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies.PLoS One. 2013;8(2):e56662. doi: 10.1371/journal.pone.0056662. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437204 Free PMC article.
-
Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose-response meta-analysis of 36,927 patients.Med Oncol. 2014 Feb;31(2):829. doi: 10.1007/s12032-013-0829-8. Epub 2014 Jan 5. Med Oncol. 2014. PMID: 24390417
Cited by
-
Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review.Cancers (Basel). 2024 Feb 16;16(4):805. doi: 10.3390/cancers16040805. Cancers (Basel). 2024. PMID: 38398199 Free PMC article. Review.
-
Mechanism and recent updates on insulin-related disorders.World J Clin Cases. 2023 Sep 6;11(25):5840-5856. doi: 10.12998/wjcc.v11.i25.5840. World J Clin Cases. 2023. PMID: 37727490 Free PMC article. Review.
-
Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH Cohort.Cancer Causes Control. 2023 Nov;34(11):983-993. doi: 10.1007/s10552-023-01747-2. Epub 2023 Jul 5. Cancer Causes Control. 2023. PMID: 37405681
-
The Role of BMI in Allostatic Load and Risk of Cancer Death.Am J Prev Med. 2023 Sep;65(3):417-426. doi: 10.1016/j.amepre.2023.03.002. Epub 2023 Mar 7. Am J Prev Med. 2023. PMID: 36889531
-
The Beneficial Effect of a Healthy Dietary Pattern on Androgen Deprivation Therapy-Related Metabolic Abnormalities in Patients with Prostate Cancer: A Meta-Analysis Based on Randomized Controlled Trials and Systematic Review.Metabolites. 2022 Oct 13;12(10):969. doi: 10.3390/metabo12100969. Metabolites. 2022. PMID: 36295871 Free PMC article. Review.
References
-
- Global Health Risks. Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009. [Accessed March 19, 2013]. http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_re....
LinkOut - more resources
Full Text Sources
Other Literature Sources